Dry eye disease (DED) is a highly prevalent ocular disorder affecting an estimated 5-50% of the global population. Despite its substantial clinical burden, effective therapeutic options remain limited owing to the multifactorial nature and complex pathophysiology of the disease. To simultaneously address the two princi...
Dan Chen, Si-Ting Sheng, Li-Rui Liu et al.· Journal of Controlled Releas...· 0 citations
A noninvasive, cornea-penetrating nanodrug based on chitosan-modified lipid-polymer hybrid nanoparticles (LPNPs) for co-delivery of lutein and VEGF-silencing siRNA (Chi@Lu/si NPs) to treat AMD, which interrupts the pathological cycle driving CNV progression.
Yong Li, Fan Xiao, Zi-Wei Liu et al.· Advances in Materials· 0 citations
Posterior Capsule Opacification (PCO) remains a prevalent long-term complication following surgery for cataract, the world's primary blinding disease, significantly compromising visual outcomes. Although intraocular lens (IOL) material is a recognized risk factor, large-scale datasets linking granular material properti...
Xiangling He, Su Li, Zeen Lv et al.· Scientific Data· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.